Equity Overview
Price & Market Data
Price: $0.0901
Daily Change: -$0.0099 / 10.99%
Range: $0.0901 - $0.10
Market Cap: $8,427,962
Volume: 59,520
Performance Metrics
1 Week: 3.83%
1 Month: 30.02%
3 Months: 6.99%
6 Months: -26.37%
1 Year: -59.41%
YTD: -16.51%
Details
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population in Canada, the United States, and Europe. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert for detecting smoking status; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, Bahamas.